Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $363.8500 (-1.87%) ($363.3200 - $374.9200) on Mon. Mar. 28, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.64% (three month average) | | RSI | 25 | | Latest Price | $363.8500(-1.87%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | REGN declines -2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(63%) XLV(51%) XBI(48%) QQQ(41%) IVW(40%) | | Factors Impacting REGN price | REGN will decline at least -1.32% in a week (0% probabilities).
VIXM(-12%) UUP(-8%) TLT(-8%) SPLV(-5%) IPO(-5%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.32% (StdDev 2.64%) | | Hourly BBV | 0 () | | Intraday Trend | -2.4% | | | | | |
|
| Resistance Level | $380.6 | | 5 Day Moving Average | $369.88(-1.63%) | | 10 Day Moving Average | $368.8(-1.34%) | | 20 Day Moving Average | $380.6(-4.4%) | | To recent high | -33.9% | | To recent low | 0% | | Market Cap | $38.579b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |